Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Medicare Advantage Special Needs Plans now make up more than a quarter of all enrollments. Learn more about what they are and ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Bhubaneswar: The Indian Army major and his betrothed, who were allegedly harassed by a group of youths and then subjected to custodial torture at Bharatpur police station on Sept 15, appeared before ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

When a diet trend goes viral on social media, the comment section is typically evenly split between skeptics and supporters.

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more than half of those aged over 30 who have the condition are not receiving ...